Vitrafy Life Sciences Raising $30m to Scale Guardion Production and US Expansion

As reported by smallcaps.com.au

Vitrafy Life Sciences (ASX: VFY) has secured firm commitments for a $30 million institutional placement to expand manufacturing of its Guardion cryopreservation...

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on smallcaps.com.au ↗

Market Samachar is a news aggregator. This article was originally published by smallcaps.com.au. Tap the button above to read the full story on their site.

COMPANIES Nifty in control of FIIs? The unlucky 13 bluechips facing the hardest institutional selloff Stocks-Markets-Economic Times
COMPANIES Cochin Shipyard among 5 F&O stocks with a sharp rise in futures open interest Stocks-Markets-Economic Times
INDIAN US-based Tryfacta files draft papers for $100-150 million GIFT City IPO Markets-Economic Times
INDIAN Never sell because you're bored': PPFAS CIO Rajeev Thakkar's 6-point guide on when to exit an investment Markets-Economic Times
COMPANIES Zee Entertainment among 4 stocks that closed crossing above VWAP Stocks-Markets-Economic Times
INDIAN Paras Defence to GRSE, Mazagon Dock: Defence stocks rise up to 4.5% today amid US-Iran peace deal buzz mint - markets
INDIAN Hexagon Nutrition shares off to a decent start, list at 7% premium over IPO price mint - markets
INDIAN Stock market today: Sensex jumps 900 points, Nifty 50 above 23,400 - 5 key reasons behind Dalal Street rally mint - markets

Vitrafy Life Sciences Raising $30m to Scale Guardion Production and US Expansion

More from Market Samachar